Compugen (CGEN) Net Cash Flow (2009 - 2010)
Compugen (CGEN) posted quarterly Net Cash Flow of $3.0 million for Q4 2010, down 68.11% year-over-year from $9.5 million in Q4 2009, and up 139.57% on a QoQ basis from -$7.6 million in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Net Cash Flow (2009 - 2010) Analysis & Trends
Compugen has reported Net Cash Flow for 2 years, with the latest figure at $3.0 million in Q4 2010.
- Net Cash Flow for Q4 2010 came in at $3.0 million, down 68.11% year-over-year; the trailing twelve-month figure through Sep 2011 was $3.0 million (up 64.35% YoY), and the FY2025 annual result was $72.2 million, up 1749.28% from the prior year.
- Net Cash Flow grew to $3.0 million in Q4 2010, from -$7.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $9.5 million in Q4 2009 and troughed at -$7.6 million in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 3.02 Mn |
| Sep 30, 2010 | -7.64 Mn |
| Dec 31, 2009 | 9.48 Mn |
| Sep 30, 2009 | -935,000.00 |